September 22, 2010

The Food and Drug Administration has approved a manufacturing plan for a drug to treat...

September 22, 2010

The Food and Drug Administration has moved to significantly restrict access to a controversial diabetes...

September 21, 2010

Abbott on Wednesday initiated a proactive, voluntary recall of certain Similac powder infant formulas in...

September 21, 2010

A U.S. District Court has blocked Canadian generic drug maker Apotex from selling generic versions...

September 21, 2010

Merck is expanding its patient assistance program, the drug maker said Wednesday....

September 20, 2010

The Food and Drug Administration has approved a generic treatment for organ transplant patients....

September 19, 2010

Biotech company Genentech has amended its application to the Food and Drug Administration seeking an...

September 16, 2010

The Food and Drug Administration has accepted for review a regulatory approval application for a...

September 16, 2010

An advisory committee of the Food and Drug Administration has given a thumbs-down to a...

September 15, 2010

Generic drugs saved Medicare Part D beneficiaries and the program as a whole $33 billion...

September 15, 2010

Drug maker Forest Pharmaceuticals will pay more than $300 million to the federal government as...

September 14, 2010

The Food and Drug Administration has extended the amount of review time for an AstraZeneca...

September 13, 2010

The lobby for the generic drug industry is joining the fight against counterfeit drugs....

September 12, 2010

The Food and Drug Administration did not completely withdraw from the market a drug used...

September 12, 2010

Starting Monday, K-V Pharmaceutical will ship its first product since it withdrew several products in...

September 9, 2010

The federal government got a kick in the face Thursday as an appeals court ruled...

September 9, 2010

Efforts by two generic drug makers to market a generic version of a drug for...

September 9, 2010

Close to 400 drugs and vaccines are in development for fighting infectious diseases, according to...

September 9, 2010

This week’s decision by the U.S. Second Circuit Court of Appeals could make political efforts...

September 8, 2010

NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial...

September 8, 2010

Hi-Tech Pharmacal had $40.4 million in sales during its fiscal first quarter ended July 31,...

September 7, 2010

Bristol-Myers Squibb will acquire Seattle-based biotech ZymoGenetics, Bristol said Wednesday....

September 7, 2010

The generics division of Pfizer will sell an authorized generic version of a drug used...

September 7, 2010

Swiss drug maker Lonza will help British drug maker GlaxoSmithKline manufacture five biotech drugs in...